Literature DB >> 25985411

Antiretroviral nanoparticles: the future is now: authors' response to editorial comments.

Jennifer P Freeling1, Rodney J Y Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25985411      PMCID： PMC4827420          DOI： 10.1097/QAD.0000000000000600

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

Review 1.  Biologic agents in rheumatoid arthritis: an update for managed care professionals.

Authors:  Sandeep K Agarwal
Journal:  J Manag Care Pharm       Date:  2011 Nov-Dec

2.  Antiretroviral nanoparticles: the future is now.

Authors:  Esteban Martínez; José L Blanco
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

3.  Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients.

Authors:  Jennifer Williams; Harlan R Sayles; Jane L Meza; Patrick Sayre; Uriel Sandkovsky; Howard E Gendelman; Charles Flexner; Susan Swindells
Journal:  Nanomedicine (Lond)       Date:  2013-04-23       Impact factor: 5.307

4.  Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood.

Authors:  Jennifer P Freeling; Josefin Koehn; Cuiling Shu; Jianguo Sun; Rodney J Y Ho
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

5.  Cutaneous injection site reactions to long-term therapy with enfuvirtide.

Authors:  Paolo Maggi; Nicoletta Ladisa; Eliana Cinori; Andrea Altobella; Giuseppe Pastore; Raffaele Filotico
Journal:  J Antimicrob Chemother       Date:  2004-02-25       Impact factor: 5.790
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.